# Raw Agent Run Log

- `run_id`: RUN_20260527_230420_15_openclaw_deepseekv4pro_isolated
- `case_id`: C008
- `variant_id`: level2
- `level`: level2
- `agent_name`: openclaw
- `agent_id`: benchmark_isolated
- `model`: deepseek-v4-pro
- `model_provider`: deepseek
- `openclaw_build_or_version`: 2026.5.5
- `channel`: cli
- `temperature`: not_supported
- `top_p`: not_supported
- `max_tokens`: not_supported
- `seed`: not_supported
- `tools_enabled`: locally_isolated_remote_tool_enabled
- `closed_book`: false
- `timestamp`: 2026-05-27T23:04:20+0800
- `input_file`: benchmark/cases/C008_retail_tax_salience/agent_task_level2.md
- `system_prompt_summary`: workspace=/Users/jiangcanxiang/OpenClawBenchmarkIsolated; thinking=high; actual_tool_use=none; agent=benchmark_isolated
- `contamination_status`: unknown
- `contamination_reason`: pending manual content review; actual tool use=none
- `status`: success

## Raw Agent Output

# Research Design: Causal Effect of Visible All-in Pricing on Consumer Demand

---

## 1. Executive Summary

This design proposes a difference-in-differences (DiD) framework with staggered treatment adoption across product categories, stores, and time periods to estimate the causal effect of making add-on charges visible at the point of product choice. The core identification strategy compares pre-to-post changes in demand for treated product-category-store cells against contemporaneous changes in untreated cells, while controlling for actual prices paid, promotions, and time-varying store and category shocks. The analysis distinguishes salience-driven demand responses from price-driven responses by holding the economic all-in price constant while varying only its display visibility. Key threats include differential pre-trends, contemporaneous promotional activity, and substitution across treated and untreated products. The design yields credible causal estimates of the visibility effect under standard parallel-trends assumptions, supported by event-study visualizations, falsification tests on pre-treatment periods, and placebo tests on untreated categories. The analysis cannot separately identify pure cognitive salience from information provision (learning), nor can it estimate long-run equilibrium effects if consumers eventually learn about add-on charges through experience.

---

## 2. Research Question

What is the causal effect of making an add-on charge visible at the point of product choice (visible all-in pricing) on consumer demand, holding the underlying economic price constant?

---

## 3. Target Estimand

**Primary estimand**: The average treatment effect on the treated (ATT) — the change in quantity demanded (or revenue) for treated product categories during the intervention period, attributable to the visibility of the add-on charge in the displayed price, relative to what demand would have been absent the display change.

Formally, for treated product-category-store cell \(i\) at time \(t\) with treatment timing \(g_i\):

\[
\tau_{ATT} = \mathbb{E}[Y_{it}(1) - Y_{it}(0) \mid D_{it} = 1]
\]

where \(Y_{it}(1)\) is demand under visible all-in pricing and \(Y_{it}(0)\) is demand under the baseline display (add-on charge not visible at point of choice), and \(D_{it}\) indicates treatment.

**If causal identification is not fully credible**, the strongest defensible estimand is the conditional difference in demand changes between treated and untreated cells, interpreted as a *partial association* between the display intervention and demand, adjusted for observable confounds.

---

## 4. Treatment/Exposure and Main Outcomes

| Concept | Variable | Operationalization |
|---|---|---|
| **Treatment** | \(D_{it}\) | Binary indicator: 1 if product-category-store cell \(i\) at time \(t\) displays the add-on charge visibly at the point of choice; 0 otherwise |
| **Treatment intensity** | \(Exposure_{it}\) | Cumulative weeks or fraction of selling periods the display is active for cell \(i\) by time \(t\) |
| **Primary outcome** | \(Q_{it}\) | Quantity sold (units) for product-category-store cell \(i\) in time period \(t\) |
| **Secondary outcome** | \(R_{it}\) | Revenue for cell \(i\) in period \(t\) |
| **Secondary outcome** | \(Subst_{it}\) | Demand in untreated adjacent categories (to assess substitution) |
| **Secondary outcome** | \(Execution_{it}\) | Any auxiliary indicator of whether the display was correctly implemented (if observed) |

---

## 5. Data Structure Summary

The data form an unbalanced panel at the product-category × store × time-period level. The structure supports:

- **Cross-sectional dimension**: Product categories (treated and untreated) across one or more stores
- **Time dimension**: Multiple pre-intervention weeks and multiple intervention weeks
- **Treatment variation**: Staggered adoption — selected categories in selected stores switch to visible all-in display at possibly different calendar times
- **Comparison groups**: (1) Untreated categories within treated stores, (2) Same categories in untreated stores, (3) Pre-intervention periods for eventually-treated cells

| Feature | Detail |
|---|---|
| Unit of observation | Product-category × store × week |
| Pre-periods | Multiple weeks before any treatment |
| Post-periods | Multiple weeks during intervention |
| Treatment assignment | Retailer-selected categories in selected stores |
| Repeated exposure | Yes — treated cells remain exposed across post-periods |
| Clustering level | Store-category or store level |

---

## 6. Relevant Causal Mechanisms

The packet identifies four mechanisms to be distinguished:

### 6.1 Salience vs. Economic Price Change
The core mechanism of interest: consumers react to the *visibility* of the total price, not to a change in the total price itself. The add-on charge was always part of the final price at checkout but was not visible during product selection. The design must hold the economic all-in price constant while varying only its display salience.

### 6.2 Store-Wide or Time-Specific Shocks
Sales may move because of seasonal patterns, local demand shocks, supply disruptions, or store-level changes (staffing, layout, foot traffic) that coincide with the intervention. These generate spurious pre-post differences that are not attributable to the visibility treatment.

### 6.3 Differential Baseline Trends
Treated product categories may differ systematically from untreated ones — for example, categories selected for the intervention may have been chosen because of rising or falling demand trends that would have continued absent treatment.

### 6.4 Promotions, Discounts, and Substitution
Measured demand changes may reflect contemporaneous promotional activity (which could be correlated with the display rollout), or consumers substituting between treated and untreated products in response to the new price information, shifting demand rather than changing total category expenditure.

---

## 7. Main Identification Challenge

The central identification problem is that treated and untreated product-category-store cells may differ in ways that independently affect demand trajectories. The retailer selects which categories and stores receive the display change — selection is non-random and may be correlated with demand characteristics (e.g., high-volume categories, stores with price-sensitive customers, categories where add-on charges are large). The challenge is to construct a credible counterfactual for what would have happened to treated cells had the display not changed.

This breaks down into four sub-problems:

1. **Selection into treatment**: Treated cells may have different baseline demand levels or trends.
2. **Confounding shocks**: Store-level or time-level events may coincide with the display change.
3. **Simultaneous price changes**: If actual shelf prices or add-on charge rates change during the intervention window, isolating the visibility effect from the price effect becomes impossible.
4. **Spillover**: Substitution toward untreated products contaminates the comparison group and biases treatment effects upward (in absolute value) if substitution reduces untreated-product demand.

---

## 8. Whether Credible Causal Identification Is Possible

**Yes, credible causal identification is possible** under the design described below, provided that:

- The add-on charge amount does not change during the analysis window, and actual shelf prices are observed and can be controlled.
- Multiple pre-intervention time periods are available to assess and support parallel pre-trends.
- At least one credible comparison group exists (untreated categories within treated stores or treated categories in untreated stores).
- The number of treated clusters is sufficient for cluster-robust inference (at minimum, treatment varies across enough store-category cells to avoid overfitting).

The primary threat that *cannot* be fully ruled out with the given data structure is the distinction between **salience** (cognitive prominence) and **information** (consumers learning the add-on charge amount for the first time). Both are consequences of the same display change, and the data cannot separately identify them without additional variation — for example, consumers who already knew the add-on charge amount versus those who did not.

---

## 9. Proposed Empirical Design

### 9.1 Core Design: Staggered Difference-in-Differences with High-Dimensional Fixed Effects

The design exploits three sources of variation:

1. **Within-store, across-category**: Compare pre-post changes for treated categories vs. untreated categories in the same store. This differences out store-level time shocks.
2. **Within-category, across-store**: Compare pre-post changes for the same category in treated stores vs. untreated stores. This differences out category-level time shocks.
3. **Within-category-store, across-time**: Compare post-treatment periods to pre-treatment periods, using the pre-period to estimate counterfactual trends.

The preferred specification combines all three, using a two-way fixed effects (TWFE) event-study framework:

**Step 1 — Event-study specification:**

\[
Y_{it} = \alpha_i + \lambda_t + \sum_{k = -K, k \neq -1}^{L} \beta_k \cdot \mathbf{1}[t - g_i = k] + \gamma \cdot X_{it} + \varepsilon_{it}
\]

where:
- \(Y_{it}\): quantity sold (log or level) for cell \(i\) at time \(t\)
- \(\alpha_i\): product-category × store fixed effect (absorbs time-invariant cell characteristics)
- \(\lambda_t\): time (week) fixed effect (absorbs common time shocks)
- \(g_i\): the first time period cell \(i\) is treated
- \(k\): event time relative to treatment (negative = pre-treatment leads)
- \(\beta_k\) for \(k < 0\): pre-treatment coefficient estimates (should be near zero under parallel trends)
- \(\beta_k\) for \(k \geq 0\): dynamic treatment effects (the causal parameters of interest)
- \(X_{it}\): vector of time-varying controls (actual price, promotions, discounts)

**Step 2 — Aggregated DiD estimator:**

\[
Y_{it} = \alpha_i + \lambda_t + \beta \cdot D_{it} + \gamma \cdot X_{it} + \varepsilon_{it}
\]

where \(D_{it} = 1\) if cell \(i\) is in a treated state at time \(t\). This yields the overall ATT, interpreted as a weighted average of period-specific effects.

**Step 3 — Saturated specification with comparison-group interactions:**

To formally separate store, category, and time shocks, estimate:

\[
Y_{it} = \alpha_i + \lambda_t + \beta \cdot D_{it} + \theta \cdot (Store_s \times Week_t) + \delta \cdot (Category_c \times Week_t) + \gamma \cdot X_{it} + \varepsilon_{it}
\]

where \(Store_s \times Week_t\) and \(Category_c \times Week_t\) are interacted fixed effects that absorb store-specific and category-specific time shocks, respectively. The treatment effect \(\beta\) is identified from variation *within* store-week and category-week cells — i.e., comparing treated and untreated categories in the same store-week, and treated and untreated stores for the same category-week.

### 9.2 Distinguishing Salience from Price Changes

The design isolates the visibility effect (not a price effect) through two features:

1. **Control for actual price paid**: Including \(Price_{it}\) and \(Discount_{it}\) as covariates absorbs demand variation driven by changes in the economic cost. If the add-on charge rate is constant over the analysis window, any residual demand shift associated with \(D_{it}\) cannot be attributed to price changes — it reflects the display change.

2. **Add-on charge rate stability check**: Verify (or assert based on institutional knowledge) that the add-on charge *rate* (e.g., tax rate, deposit fee, recycling charge) does not change during the analysis window. If the charge rate changes, the design must control for \(Price_{it} + Charge_{it}\) directly and interpret \(D_{it}\) as the effect of visibility *given* the total price.

### 9.3 Addressing Staggered Treatment Concerns

If treatment timing varies across cells, the static TWFE estimator may produce biased estimates due to "forbidden comparisons" (using already-treated cells as controls for later-treated cells) when treatment effects are dynamic (Goodman-Bacon decomposition; Sun & Abraham 2021; Callaway & Sant'Anna 2021). To address this:

- **Primary specification**: Use the Sun-Abraham or Callaway-Sant'Anna estimator that constructs treatment effects by cohort and avoids using already-treated units as controls. Aggregate cohort-time-specific effects into an overall ATT.
- **Robustness**: Report the Goodman-Bacon decomposition to quantify the contribution of each 2×2 comparison type. If "later-treated vs. already-treated" comparisons are a small share, the static TWFE is less concerning.
- **Simplest case**: If all treated cells start treatment in the same period (no staggering), the standard TWFE DiD is unbiased under parallel trends.

---

## 10. Why the Design Is Valid

### 10.1 Internal Validity

The event-study framework provides direct visual evidence on the key identifying assumption — parallel pre-trends. If \(\beta_k \approx 0\) for all \(k < 0\), the treated and untreated cells evolved similarly before the intervention, supporting the claim that untreated cells provide a valid counterfactual.

The high-dimensional fixed effect structure absorbs:
- **Permanent cell differences** (\(\alpha_i\)): baseline demand levels, product characteristics, store characteristics
- **Common time shocks** (\(\lambda_t\)): seasonality, holidays, chain-wide policy changes
- **Store-specific time shocks** (\(Store_s \times Week_t\)): local demand conditions, store staffing or layout changes
- **Category-specific time shocks** (\(Category_c \times Week_t\)): category-level promotions, supply disruptions, national advertising

The specification with both store-week and category-week fixed effects identifies the treatment effect from triple-difference logic — comparing the treated-vs-untreated difference *within* a category *within* a store-week. This is the most demanding specification and is credible if treatment varies across categories within the same store-week.

### 10.2 Construct Validity

The treatment variable directly captures the construct of interest — whether the add-on charge is visible at the point of choice. By controlling for the actual price paid, the design isolates the visibility channel from the price channel, directly mapping to the salience construct.

---

## 11. Required Assumptions

| # | Assumption | Justification / Testability |
|---|---|---|
| A1 | **Parallel trends**: Absent treatment, treated and untreated cells would have followed parallel demand trajectories. | Partially testable via pre-trend coefficients \(\beta_k\) for \(k < 0\). Cannot be tested for the post-period. |
| A2 | **No anticipation**: Demand in treated cells does not respond to the treatment before it is implemented. | Testable: check \(\beta_{-1} \approx 0\) in event study. Supported if display change is unannounced. |
| A3 | **Stable unit treatment value (SUTVA)**: Treatment of one cell does not affect outcomes of other cells, except through channels modeled as outcomes (substitution). | Partially testable: estimate spillover models. Relaxed if spillover is measured as a secondary outcome. |
| A4 | **Constant add-on charge rate**: The add-on charge rate does not change during the analysis window. | Verifiable from transaction data if the add-on charge is recorded separately. If not verifiable, must be asserted from institutional knowledge. |
| A5 | **No differential attrition**: Treated and untreated cells do not differentially exit the sample (e.g., product discontinuation). | Testable: compare attrition rates and baseline characteristics of attriting cells by treatment status. |
| A6 | **Correct specification of fixed effects**: The additive fixed effect structure adequately captures unobserved heterogeneity. | Not directly testable; assessed via robustness to alternative fixed effect structures. |
| A7 | **No contemporaneous confounding interventions**: No other store or category changes (layout, staffing, advertising) coincide with the display change. | Partially addressed by store-week and category-week fixed effects; cannot fully rule out cell-specific changes. |

---

## 12. Statistical Model / Analysis Equation

### Primary specification

For unit \(i\) (product-category × store), time \(t\) (week):

**Event-study (dynamic effects):**

\[
\ln(Q_{it}) = \alpha_i + \lambda_t + \sum_{k = -K, k \neq -1}^{L} \beta_k \cdot \mathbf{1}[t - g_i = k] + \gamma_1 \ln(Price_{it}) + \gamma_2 Promo_{it} + \gamma_3 Disc_{it} + \varepsilon_{it}
\]

with standard errors clustered at the store-category level (the level of treatment assignment).

**Aggregated ATT (static):**

\[
\ln(Q_{it}) = \alpha_i + \lambda_t + \beta \cdot D_{it} + \gamma_1 \ln(Price_{it}) + \gamma_2 Promo_{it} + \gamma_3 Disc_{it} + \varepsilon_{it}
\]

**Saturated (with comparison-group interactions):**

\[
\ln(Q_{it}) = \alpha_i + \lambda_t + \beta \cdot D_{it} + \theta_{st} + \delta_{ct} + \gamma \cdot X_{it} + \varepsilon_{it}
\]

where \(\theta_{st}\) are store × week fixed effects and \(\delta_{ct}\) are category × week fixed effects.

**Staggered-treatment robust specification** (using Callaway-Sant'Anna or Sun-Abraham estimator):

- Estimate group-time average treatment effects \(ATT(g, t)\) for each treatment cohort \(g\) at each event time \(t\).
- Aggregate to overall ATT using cohort-size or precision weights.
- Report event-study of aggregated dynamic effects.

### Inference

- Cluster standard errors at the store-category level (the level at which treatment varies).
- If treatment is assigned at the store level (all categories in a store are treated simultaneously), cluster at the store level and recognize that the number of clusters may be small. In that case, use wild cluster bootstrap or randomization inference.
- Report conventional (non-clustered) and clustered standard errors for transparency.

---

## 13. Robustness, Placebo, Falsification, and Diagnostic Tests

### 13.1 Pre-Trend Tests

- **Visual**: Plot event-study coefficients \(\beta_k\) for \(k < 0\) with 95% confidence intervals. Visual inspection for systematic pre-trends.
- **Joint test**: \(F\)-test of \(H_0: \beta_{-K} = \beta_{-K+1} = \cdots = \beta_{-2} = 0\). Failure to reject supports parallel pre-trends.
- **Linear pre-trend test**: Include a linear pre-trend term interacted with treatment status. If the interaction is insignificant, differential linear trends are not detected.

### 13.2 Placebo Tests

- **In-time placebo**: Shift the pseudo-treatment date backward by \(m\) periods (e.g., 4 weeks before actual treatment). Estimate the DiD model on pre-treatment data only. A significant "effect" at the pseudo-treatment date suggests pre-existing differential trends.
- **In-category placebo**: Apply the treatment indicator to a randomly selected set of *untreated* categories and estimate the DiD. Repeat for many random draws (permutation test). The actual estimate should be in the tails of the permutation distribution.
- **In-store placebo**: If multiple stores are available and some are untreated, assign pseudo-treatment to untreated stores and test for a spurious effect.

### 13.3 Robustness Checks

- **Alternative outcome measures**: Replicate using revenue instead of quantity; using transaction counts instead of quantity; using category share of store revenue.
- **Alternative functional forms**: Poisson pseudo-maximum likelihood (PPML) for count outcomes; linear (non-log) specification; inverse hyperbolic sine transformation for outcomes with zeros.
- **Alternative fixed effect structures**: Store FE + category FE + week FE (no interactions); store-week FE only; category-week FE only; product-level FE instead of product-category FE.
- **Balanced panel**: Restrict to cells present in all periods to rule out composition effects from entry/exit.
- **Drop the transition period**: Exclude the week the display change is implemented to allow for execution imperfections.
- **Leave-one-out**: Drop one store or one category at a time and re-estimate to assess influence of individual clusters.
- **Varying bandwidth**: Restrict the analysis to ±\(k\) weeks around treatment to reduce influence of distant periods.

### 13.4 Diagnostics

- **Goodman-Bacon decomposition**: Decompose the static TWFE estimator into its constituent 2×2 comparisons (treated vs. never-treated, treated vs. not-yet-treated, etc.) and report weights.
- **Balance tests**: Regress pre-treatment characteristics (pre-period average demand, price levels, promotion frequency) on treatment status. Report standardized differences.
- **Attrition analysis**: Compare the proportion and characteristics of cells that exit the sample in treated vs. untreated groups.

---

## 14. Heterogeneity Analysis (If Supportable)

Whether heterogeneity analysis is supportable depends on the number of treated cells and the richness of pre-treatment data. If the number of treated store-category cells is sufficient:

### 14.1 By Add-on Charge Magnitude

If the add-on charge varies across products (e.g., as a percentage of base price or an absolute amount), test whether the visibility effect is larger for products where the charge represents a larger share of the total price. Specification:

\[
\ln(Q_{it}) = \alpha_i + \lambda_t + \beta_1 D_{it} + \beta_2 D_{it} \times ChargeShare_i + \gamma X_{it} + \varepsilon_{it}
\]

Prediction: larger demand response when the charge is a larger fraction of the shelf price.

### 14.2 By Product Characteristics

If product-level covariates are available (e.g., price tier, brand vs. private label, necessity vs. discretionary), test interactions:

\[
\ln(Q_{it}) = \alpha_i + \lambda_t + \beta_1 D_{it} + \beta_2 D_{it} \times Char_i + \gamma X_{it} + \varepsilon_{it}
\]

Relevant dimensions: price elasticity of the category (more elastic categories should show larger quantity responses), whether the product is typically purchased on price comparison, and whether the product is an impulse or planned purchase.

### 14.3 By Time Since Treatment

The event-study specification already provides this: \(\beta_k\) for \(k \geq 0\) traces out the dynamic response. Test whether effects decay, persist, or grow with repeated exposure. Decay would be consistent with an initial attention effect that fades; persistence would be consistent with information provision (consumers incorporate the new information into their permanent decision rule).

### 14.4 Caution

Subgroup analyses divide the already-limited treated sample. All heterogeneity estimates should be reported with the caveat that they are exploratory unless pre-registered. Multiple hypothesis testing corrections should be applied.

---

## 15. Measurement, Compliance, Missingness, Spillover, and Implementation Limits

### 15.1 Measurement

- **Treatment implementation fidelity**: The packet notes that store execution may be imperfect — tags misplaced, missing, or implemented late. The estimated treatment effect is an *intent-to-treat* (ITT) effect of the retailer's *decision* to implement, not necessarily the effect of actual consumer exposure to the visible display. If execution fidelity data are available (e.g., audit reports of tag placement), an instrumental variables approach can recover the complier average causal effect (LATE), using the assigned treatment as an instrument for actual display visibility. Without execution data, the ITT interpretation must be explicit.
- **Price measurement**: If the add-on charge is recorded only at checkout and not itemized separately in the data, the design cannot control for the all-in price directly and must rely on the assumption that the add-on charge rate is constant over the analysis window.

### 15.2 Compliance / Take-Up

- Compliance is measured at the store level: did the store actually apply the display change to the assigned categories?
- If compliance data are unavailable, the treatment indicator \(D_{it}\) captures assignment, not receipt. This attenuates the estimated effect toward zero.

### 15.3 Missingness and Attrition

- **Stockouts**: If treated products stock out more frequently after the intervention (e.g., because the visible charge reduces demand and the retailer reduces inventory), observed sales become a selected sample. Compare stockout rates by treatment status, and consider a Heckman-type selection correction or a bounding approach (e.g., Lee bounds).
- **Product entry/exit**: Products entering or exiting during the analysis window create an unbalanced panel. The fixed effects absorb permanent differences for products present in both periods, but if treated products differentially exit (e.g., low-selling products are dropped), the composition of treated cells changes. Sensitivity: restrict to products present in all periods and compare estimates.
- **Scanner recording problems**: If recording errors are random across treated and untreated cells, they inflate standard errors but do not bias estimates. If recording errors are correlated with the display change (e.g., new tag system introduces scanning issues), bias is possible.

### 15.4 Spillover and Interference

SUTVA (Assumption A3) may be violated in at least two ways:

1. **Substitution spillover**: Consumers may switch from treated to untreated products within the same category or to adjacent categories. This biases the treatment effect *upward* (demand shifts from treated to untreated products make the treated-untreated gap larger) and contaminates the comparison group. Mitigation:
   - Define comparison categories that are *not* close substitutes for treated categories (e.g., different aisles, different use cases).
   - Estimate a spillover model: include a variable measuring the "distance" or "substitutability" of each untreated product to the nearest treated product, and test whether demand changes in untreated products vary with this distance.
   - Report category-level (aggregated) outcomes that net out within-category substitution.

2. **Attention spillover**: The visible display on treated products may draw consumer attention to *all* prices, including untreated products, making shoppers more price-conscious generally. This would bias the treatment estimate toward zero (untreated demand also responds to the treatment). Mitigation:
   - This is inherently difficult to detect without a pure control group that is completely isolated from the intervention. Use geographically separate stores as a control if some stores are entirely untreated.
   - If only some stores receive the intervention, compare untreated categories in treated stores to the same categories in untreated stores.

---

## 16. Failure Modes and Alternative Explanations

| Failure Mode | Likelihood | Mitigation / Detection |
|---|---|---|
| **Differential pre-trends**: Treated categories were already on a different trajectory. | Moderate | Pre-trend test; in-time placebo; balance on pre-period trends |
| **Contemporaneous price changes**: Shelf prices changed at the same time as the display change. | Moderate | Control for actual prices; test whether prices changed differentially at treatment |
| **Promotional confounding**: Treated products received more/fewer promotions during the intervention. | Moderate | Control for promotion indicators; test for differential promotion frequency around treatment |
| **Hawthorne effects**: Store staff or shoppers change behavior because they know they are being studied. | Low-Moderate | Difficult to rule out without blinded implementation; compare to "business-as-usual" changes |
| **Substitution to untreated products**: Demand shifts rather than changes, inflating treatment effects. | Moderate | Analyze category-level outcomes; test for demand changes in adjacent categories |
| **Simultaneous store changes**: Store layout, staffing, or advertising changes coincided with the display intervention. | Low-Moderate | Store-week fixed effects absorb all store-level changes in a given week; only cell-specific changes remain |
| **Learning/experience effects**: Consumers learn about add-on charges through repeated purchase experience regardless of display. | Low in short run | Event-study dynamics; if effects decay, consistent with attention rather than learning |
| **Reverse causality**: Retailer implemented the display change in categories where demand was already changing. | Low-Moderate | Pre-trend test directly addresses this; interview-based evidence on retailer's implementation decision process |
| **Small number of clusters**: Inference is unreliable with few treated clusters. | Depends on data | Wild cluster bootstrap; randomization inference; Fisher's exact test for small samples |

**Primary alternative explanation**: The observed demand change reflects not salience per se but *information provision* — consumers did not previously know the amount of the add-on charge and the display provides new information. With the current design, these are empirically equivalent. To separate them would require data on consumers' prior knowledge of the add-on charge (e.g., survey measures) or a design that varies visibility holding information constant (e.g., all consumers are informed of the charge amount, but only some see it on the shelf tag).

---

## 17. What Cannot Be Claimed

1. **Pure salience (as distinct from information)**: The design estimates the combined effect of making the add-on charge visible. This effect operates through both (a) increasing the cognitive salience of a charge consumers already knew about and (b) providing new information to consumers who were previously unaware of the charge. These cannot be separated without additional data on consumer knowledge.

2. **Long-run equilibrium effects**: The intervention window covers multiple weeks. If consumers eventually learn about add-on charges through experience (checkout receipts, word of mouth, media), the estimated effect may overstate the long-run impact. The design captures short-to-medium-run demand responses only.

3. **Welfare effects**: Changes in quantity demanded do not directly imply welfare changes. Consumers may be better off (making more informed choices) or worse off (overreacting to a charge that is small relative to the total expenditure) — the demand data alone cannot distinguish these.

4. **General equilibrium or market-wide effects**: The estimates are specific to the retailer, product categories, and time period studied. External validity to other retailers, product categories, charge types, or jurisdictions is not established.

5. **Mechanism-specific magnitudes**: The design cannot decompose the total effect into fractions attributable to salience, information, attention, or any other cognitive channel.

6. **Effects on total consumer expenditure**: If substitution to untreated products is substantial, the category-level demand effect may be near zero even if product-level effects are large. The design cannot speak to whether consumers spend less in total without data on spending outside the retailer.

7. **Causal effect of any *specific* display format**: The treatment is a binary indicator for "visible all-in price." If the retailer uses a specific visual format (e.g., larger font, color highlighting), the estimated effect is for that specific implementation. Different display formats may produce different effects.

---

## 18. Additional Data Needed

| Data Element | Why Needed | Priority |
|---|---|---|
| **Itemized add-on charge amount per transaction** | To control for all-in price directly and verify that the charge rate is constant. | High |
| **Execution fidelity / compliance audit data** | To estimate complier-average effects rather than intent-to-treat. Without this, the ITT interpretation must be used. | High |
| **Consumer survey on add-on charge awareness** | To separate salience (known charge, now visible) from information (previously unknown charge). | Medium |
| **Product-level characteristics** (brand, price tier, package size, category type) | To conduct heterogeneity analysis and improve covariate balance. | Medium |
| **Store-level characteristics** (size, format, demographics of catchment area) | To assess external validity and explore treatment effect heterogeneity by store type. | Low |
| **Longer post-intervention window** (months rather than weeks) | To assess persistence of effects and distinguish attention from learning. | Medium |
| **Geographically separated control stores with no intervention** | To provide a pure control group uncontaminated by within-store spillover. | Medium |
| **Pre-intervention data on product entry/exit and stockouts** | To model selection and attrition patterns. | Medium |
| **Detailed promotion calendar and discount depth** | To better control for promotional confounding. | High |
| **Documentation of the retailer's implementation decision process** | To understand treatment selection and assess selection-on-observables plausibility. | Low |

---

## 19. Threat-Response Table

The task packet does not explicitly request a threat-response table, but I provide one for completeness.

| Threat | Response Strategy | Detectability | Residual Risk |
|---|---|---|---|
| **Non-parallel pre-trends** | Event-study visualization; joint F-test on pre-period coefficients; in-time placebo | Directly testable | Cannot test parallel trends in post-period |
| **Add-on charge rate changes during intervention** | Verify from transaction data; control for all-in price directly | Testable if charge is itemized | If unmeasured, cannot separate price from visibility |
| **Contemporaneous promotional activity** | Control for promotion indicators; test for differential promotion frequency at treatment threshold | Testable if promotions are recorded | Unrecorded promotions remain a confound |
| **Within-store spillover to untreated categories** | Use untreated-store comparison; estimate spatial/substitution spillover models | Partially testable | Attention spillover to all categories in treated stores is difficult to detect |
| **Staggered treatment negative weighting** | Callaway-Sant'Anna or Sun-Abraham estimator; Goodman-Bacon decomposition | Directly testable | Estimators rely on correct specification of comparison group |
| **Small number of clusters** | Wild cluster bootstrap; randomization inference | Detectable (known N) | Low power; imprecise estimates |
| **Differential attrition / product exit** | Compare attrition rates; Lee bounds; balanced-panel sensitivity | Testable | Bounds may be wide |
| **Selection into treatment** | Balance tests on observables; pre-trend tests for unobservables | Observable selection is testable; unobservable selection is not | Selection on unobservables after controlling for cell FE remains |
| **Information vs. salience** | Cannot separate without additional data | Not testable with current data | Fundamental identification limitation |

---

## 20. Claim-Evidence Table

| # | Claim | Evidence Used | Claim Type | Confidence | What Would Falsify This Claim |
|---|---|---|---|---|---|
| C1 | Making add-on charges visible at the point of choice reduces (or changes) quantity demanded for treated products. | DiD estimate \(\hat{\beta}\) on treated products; event-study coefficients \(\hat{\beta}_k\) for \(k \geq 0\) | Causal (under assumptions A1–A7) | Moderate to High | \(\hat{\beta}\) not statistically distinguishable from zero; event-study shows no clear break at treatment |
| C2 | The demand effect is driven by visibility rather than by a change in the economic price. | Price controls in regression; constant add-on charge rate verified; \(\hat{\beta}\) remains significant after controlling for \(Price_{it}\) | Causal mechanism | Moderate | \(\hat{\beta}\) becomes insignificant when actual price is included; charge rate changed during intervention |
| C3 | Treated and untreated cells followed parallel demand trends before the intervention. | Pre-period event-study coefficients \(\hat{\beta}_k \approx 0\) for \(k < 0\); joint F-test fails to reject | Descriptive / diagnostic | As reported by test power | Significant pre-trend coefficients; joint F-test rejects; visual pre-trend divergence |
| C4 | The demand effect persists (or decays) over time. | Event-study dynamics \(\hat{\beta}_k\) for \(k = 0, 1, \dots, L\) | Descriptive | Moderate | Wide confidence intervals prevent distinguishing persistence from decay |
| C5 | Consumers substitute from treated to untreated products. | Secondary outcome: demand in adjacent untreated categories increases after treatment | Descriptive / suggestive of mechanism | Low to Moderate | No detectable change in adjacent-category demand |
| C6 | The estimated effect is not driven by a single store or category. | Leave-one-out estimates remain stable; no single cluster dominates the Goodman-Bacon decomposition | Descriptive / robustness | Moderate to High | Effect disappears when one store or category is dropped |
| C7 | The effect is larger for products where the add-on charge is a larger share of the shelf price. | Significant interaction \(D_{it} \times ChargeShare_i\) | Descriptive / suggestive of mechanism | Low to Moderate (exploratory) | Interaction coefficient near zero; opposite sign |
| C8 | The estimated effect is not an artifact of staggered timing. | Callaway-Sant'Anna or Sun-Abraham estimates are similar to static TWFE; Goodman-Bacon decomposition shows limited problematic comparisons | Descriptive / robustness | Moderate to High | Alternative estimators produce substantially different estimates |
| C9 | The effect reflects the visibility display, not contemporaneous promotions. | \(\hat{\beta}\) is stable with and without promotion controls; no differential promotion timing at treatment | Causal mechanism (partial) | Moderate | \(\hat{\beta}\) changes substantially when promotions are added; promotions spike at treatment boundary |
| C10 | The effect is specific to the short-to-medium run and cannot be extrapolated to long-run equilibrium. | Logical / design constraint | Logical claim | High | N/A (this is a statement of limitation, not a testable empirical claim about the data) |

---

## Summary of Design Architecture

```
Identification:  Staggered Difference-in-Differences
                 (with Callaway-Sant'Anna / Sun-Abraham if timing varies)

Comparison:      ┌─ Untreated categories × Treated stores
                 ├─ Treated categories × Untreated stores
                 └─ Pre-treatment periods (dynamic counterfactual)

Fixed effects:   α_i (cell), λ_t (week), optionally θ_st, δ_ct

Key control:     Price paid — to separate visibility from price changes

Inference:       Cluster at treatment assignment level (store-category)
                 Wild bootstrap / randomization if few clusters

Key test:        Pre-trend visual + F-test — event-study β_k ≈ 0 for k < 0

Key limitation:  Cannot separate salience from information provision
```

## Tool Log Summary

- actual tool use: none
- trajectory `toolMetas`: []
- toolCall count: 0
- toolResult count: 0
- session_id: isolated_20260527_230420_98725_15
- session_log: /Users/jiangcanxiang/.openclaw/agents/benchmark_isolated/sessions/isolated_20260527_230420_98725_15.jsonl
- trajectory_log: /Users/jiangcanxiang/.openclaw/agents/benchmark_isolated/sessions/isolated_20260527_230420_98725_15.trajectory.jsonl

## Operator Notes

- duration_ms: 282402
- stderr_excerpt: [plugins] plugins.allow is empty; discovered non-bundled plugins may auto-load: qqbot (/Users/jiangcanxiang/.openclaw/npm/node_modules/@openclaw/qqbot/dist/index.js), openclaw-weixin (/Users/jiangcanxiang/.openclaw/npm/node_modules/@tencent-weixin/openclaw-weixin/dist/index.js). Set plugins.allow to explicit trusted ids. [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/0-autoresearch-skill resolved=~/.orchestra/skills/0-autoresearch-skill [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/brainstorming-research-ideas resolved=~/.orchestra/skills/21-research-ideation/brainstorming-research-ideas [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/creative-thinking-for-research resolved=~/.orchestra/skills/21-research-ideation/creative-thinking-for-research [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed r
